Product
13-cis Retinoic Acid
1 clinical trial
1 indication
Indication
High-risk NeuroblastomaClinical trial
An Open-Label, Multi-Center, Single-Arm, Phase 1 Study Evaluating the Safety and Pharmacokinetics of Dinutuximab Beta as Maintenance Therapy in Chinese Patients With High-Risk NeuroblastomaStatus: Completed, Estimated PCD: 2023-06-28